glp-1 agonist depression Receptor Agonists and Research to Treat Overeating and Substance Use Disorders Recent updates on GLP-1 agonists:

Since type 2 diabetes mellitus (T2DM) is a risk factor for Alzheimers disease (AD) and both have the same pathogenesis (e.g., insulin resistance), drugs use...

The global obesity treatment market is expanding at unprecedented speed, with sales of weight-loss medications forecast to rise dramatically over the next decade.

(ii) compound 2 and GLP-1

This review summarizes comparative evidence for providers who are determining which of the two classes may be the most appropriate for a specific patient

GLP-1 is a hormone that the gut produces after eating to regulate blood sugar, slow digestion and manage hunger

Purpose Chronic kidney disease (CKD) is one of the most common complications of type 2 diabetes (T2D), and CKD-related disability and mortality are increasing despite the recent advances in diabetes management